Literature DB >> 27439313

Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.

Shannon E Boye1, John J Alexander2, C Douglas Witherspoon3, Sanford L Boye1, James J Peterson1, Mark E Clark3, Kristen J Sandefer4, Chris A Girkin3, William W Hauswirth1, Paul D Gamlin3.   

Abstract

Adeno-associated virus (AAV) has emerged as the preferred vector for targeting gene expression to the retina. Subretinally injected AAV can efficiently transduce retinal pigment epithelium and photoreceptors in primate retina. Inner and middle primate retina can be transduced by intravitreally delivered AAV, but with low efficiency. This is due to dilution of vector, potential neutralization of capsid because it is not confined to the immune-privileged retinal compartment, and the presence of the inner limiting membrane (ILM), a barrier separating the vitreous from the neural retina. We here describe a novel "subILM" injection method that addresses all three issues. Specifically, vector is placed in a surgically induced, hydrodissected space between the ILM and neural retina. In an initial experiment, we injected viscoelastic (Healon(®)), a substance we confirmed was biocompatible with AAV, to create a subILM bleb and subsequently injected AAV2-GFP into the bleb after irrigation with basic salt solution. For later experiments, we used a Healon-AAV mixture to place single, subILM injections. In all cases, subILM delivery of AAV was well tolerated-no inflammation or gross structural changes were observed by ophthalmological examination or optical coherence tomography. In-life fluorescence imaging revealed profound transgene expression within the area of the subILM injection bleb that persisted for the study duration. Uniform and extensive transduction of retinal ganglion cells (RGCs) was achieved in the areas beneath the subILM bleb. Transduction of Müller glia, ON bipolar cells, and photoreceptors was also observed. Robust central labeling from green fluorescent protein-expressing RGCs confirmed their continued survival, and was observed in the lateral geniculate nucleus, the superior colliculus, and the pretectum. Our results confirm that the ILM is a major barrier to transduction by AAV in primate retina and that, when it is circumvented, the efficiency and depth to which AAV2 promotes transduction of multiple retinal cell classes are greatly enhanced.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27439313      PMCID: PMC4991591          DOI: 10.1089/hum.2016.085

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  63 in total

Review 1.  Production of recombinant adeno-associated virus vectors.

Authors:  S Zolotukhin
Journal:  Hum Gene Ther       Date:  2005-05       Impact factor: 5.695

2.  Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN.

Authors:  Dennis M Dacey; Hsi-Wen Liao; Beth B Peterson; Farrel R Robinson; Vivianne C Smith; Joel Pokorny; King-Wai Yau; Paul D Gamlin
Journal:  Nature       Date:  2005-02-17       Impact factor: 49.962

3.  Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity.

Authors:  S Hattar; H W Liao; M Takao; D M Berson; K W Yau
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

4.  In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous.

Authors:  Deniz Dalkara; Leah C Byrne; Ryan R Klimczak; Meike Visel; Lu Yin; William H Merigan; John G Flannery; David V Schaffer
Journal:  Sci Transl Med       Date:  2013-06-12       Impact factor: 17.956

5.  Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.

Authors:  Deniz Dalkara; Kathleen D Kolstad; Natalia Caporale; Meike Visel; Ryan R Klimczak; David V Schaffer; John G Flannery
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

6.  Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.

Authors:  William J Feuer; Joyce C Schiffman; Janet L Davis; Vittorio Porciatti; Phillip Gonzalez; Rajeshwari D Koilkonda; Huijun Yuan; Anil Lalwani; Byron L Lam; John Guy
Journal:  Ophthalmology       Date:  2015-11-19       Impact factor: 12.079

7.  Double peeling during vitrectomy for macular pucker: the Charles L. Schepens Lecture.

Authors:  Stanley Chang; Emily M Gregory-Roberts; Sungpyo Park; Ketan Laud; Scott D Smith; Quan V Hoang
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

8.  Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.

Authors:  Renee C Ryals; Sanford L Boye; Astra Dinculescu; William W Hauswirth; Shannon E Boye
Journal:  Mol Vis       Date:  2011-04-29       Impact factor: 2.367

9.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

Authors:  Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra
Journal:  Lancet       Date:  2014-01-16       Impact factor: 79.321

10.  Melanopsin-expressing ganglion cells on macaque and human retinas form two morphologically distinct populations.

Authors:  Hsi-Wen Liao; Xiaozhi Ren; Beth B Peterson; David W Marshak; King-Wai Yau; Paul D Gamlin; Dennis M Dacey
Journal:  J Comp Neurol       Date:  2016-04-01       Impact factor: 3.215

View more
  34 in total

Review 1.  Assessing retinal ganglion cell damage.

Authors:  C A Smith; J R Vianna; B C Chauhan
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 2.  Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques.

Authors:  Galaxy Y Cho; Kyle Bolo; Karen Sophia Park; Jesse D Sengillo; Stephen H Tsang
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

3.  Delivery of human erythropoietin gene with an adeno-associated virus vector through parotid glands to treat renal anaemia in a swine model.

Authors:  C Ma; Z Fan; Z Gao; S Wang; Z Shan
Journal:  Gene Ther       Date:  2017-07-28       Impact factor: 5.250

4.  Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants.

Authors:  Luke A Wiley; Erin R Burnight; Emily E Kaalberg; Chunhua Jiao; Megan J Riker; Jennifer A Halder; Meagan A Luse; Ian C Han; Stephen R Russell; Elliott H Sohn; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Hum Gene Ther       Date:  2018-02-23       Impact factor: 5.695

5.  Noninvasive gene delivery to foveal cones for vision restoration.

Authors:  Hanen Khabou; Marcela Garita-Hernandez; Antoine Chaffiol; Sacha Reichman; Céline Jaillard; Elena Brazhnikova; Stéphane Bertin; Valérie Forster; Mélissa Desrosiers; Céline Winckler; Olivier Goureau; Serge Picaud; Jens Duebel; José-Alain Sahel; Deniz Dalkara
Journal:  JCI Insight       Date:  2018-01-25

6.  The primate model for understanding and restoring vision.

Authors:  Serge Picaud; Deniz Dalkara; Katia Marazova; Olivier Goureau; Botond Roska; José-Alain Sahel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

7.  Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.

Authors:  William A Beltran; Artur V Cideciyan; Shannon E Boye; Guo-Jie Ye; Simone Iwabe; Valerie L Dufour; Luis Felipe Marinho; Malgorzata Swider; Mychajlo S Kosyk; Jin Sha; Sanford L Boye; James J Peterson; C Douglas Witherspoon; John J Alexander; Gui-Shuang Ying; Mark S Shearman; Jeffrey D Chulay; William W Hauswirth; Paul D Gamlin; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Mol Ther       Date:  2017-05-27       Impact factor: 11.454

8.  Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque.

Authors:  K Tyler McCullough; Sanford L Boye; Diego Fajardo; Kaitlyn Calabro; James J Peterson; Christianne E Strang; Dibyendu Chakraborty; Sebastian Gloskowski; Scott Haskett; Steven Samuelsson; Haiyan Jiang; C Douglas Witherspoon; Paul D Gamlin; Morgan L Maeder; Shannon E Boye
Journal:  Hum Gene Ther       Date:  2018-12-20       Impact factor: 5.695

Review 9.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

Review 10.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.